Graham Doyle from UBS retains his positive opinion on the stock with a Buy rating. The target price has been revised downwards and is now set at EUR 148 as compared to EUR 162 previously. | April 25, 2023
In a research note, Berenberg analyst Beatrice Allen has maintained his recommendation on the stock with a Neutral rating. The target price is unchanged and still at EUR 138. | April 20, 2023
EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word: Change in Forecast/Half Year Results
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin –. | April 19, 2023
A lowered forecast range for profitability by Carl Zeiss Meditec put the share price under considerable pressure on Wednesday. At the low for the day, the papers of the technology group slid by almost. | April 19, 2023